Umpqua Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Sell
3,594
-1,142
-24% -$1.17M 0.97% 22
2026
Q1
$4.36M Sell
4,736
-98
-2% -$99.4K 1.24% 19
2025
Q4
$5.2M Sell
4,834
-379
-7% -$362K 1.44% 14
2025
Q3
$4.31M Buy
5,213
+274
+6% +$204K 1.2% 16
2025
Q2
$3.84M Buy
4,939
+253
+5% +$197K 1.17% 16
2025
Q1
$3.87M Buy
4,686
+308
+7% +$256K 1.34% 14
2024
Q4
$3.26M Buy
4,378
+2,873
+191% +$2.38M 1.13% 19
2024
Q3
$1.33M Buy
1,505
+739
+96% +$664K 0.49% 61
2024
Q2
$694K Sell
766
-15
-2% -$12K 0.27% 81
2024
Q1
$608K Buy
+781
New +$556K 0.25% 94

Other funds holding LLY

Umpqua Bank's LLY Position: Q2 2026 in Review

Umpqua Bank reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $1.17M and leaving 3,594 shares worth $4.31M. The position accounts for 0.97% of the portfolio, ranked #22.

Umpqua Bank first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.2M in Q4 2025. 4,544 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Umpqua Bank held 3,594 shares of Eli Lilly worth $4.31M as of Q2 2026.
  • Umpqua Bank sold 1,142 Eli Lilly shares in Q2 2026, an estimated $1.17M.
  • Eli Lilly made up 0.97% of Umpqua Bank's portfolio in Q2 2026, its #22 holding.
  • Umpqua Bank first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Umpqua Bank's Eli Lilly position peaked at $5.2M in Q4 2025.
  • 4,544 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.